212 related articles for article (PubMed ID: 15871663)
1. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
Xiang J; Martinez-Smith C; Gale M; Chang Q; Labrecque DR; Schmidt WN; Stapleton JT
J Interferon Cytokine Res; 2005 May; 25(5):261-70. PubMed ID: 15871663
[TBL] [Abstract][Full Text] [Related]
2. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
Antiviral Res; 2001 Dec; 52(3):241-9. PubMed ID: 11675141
[TBL] [Abstract][Full Text] [Related]
3. Influence of RNA titre and amino acid changes in the NS5A region of GB virus c/hepatitis G virus on the effectiveness of interferon therapy.
Fujisawa T; Horiike N; Michitaka K; Onji M
J Gastroenterol Hepatol; 2000 Jun; 15(6):632-9. PubMed ID: 10921417
[TBL] [Abstract][Full Text] [Related]
4. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.
Murphy MD; Rosen HR; Marousek GI; Chou S
Dig Dis Sci; 2002 Jun; 47(6):1195-205. PubMed ID: 12064791
[TBL] [Abstract][Full Text] [Related]
5. Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy.
Kato T; Mizokami M; Orito E; Ohba K; Nakano T; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Yasuda K; Iino S
J Med Virol; 1999 Apr; 57(4):376-82. PubMed ID: 10089050
[TBL] [Abstract][Full Text] [Related]
6. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.
Noguchi T; Satoh S; Noshi T; Hatada E; Fukuda R; Kawai A; Ikeda S; Hijikata M; Shimotohno K
Microbiol Immunol; 2001; 45(12):829-40. PubMed ID: 11838900
[TBL] [Abstract][Full Text] [Related]
7. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin.
Hung CH; Lee CM; Lu SN; Lee JF; Wang JH; Tung HD; Chen TM; Hu TH; Chen WJ; Changchien CS
J Viral Hepat; 2003 Mar; 10(2):87-94. PubMed ID: 12614464
[TBL] [Abstract][Full Text] [Related]
10. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells.
Xiang J; McLinden JH; Chang Q; Kaufman TM; Stapleton JT
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15570-5. PubMed ID: 17030806
[TBL] [Abstract][Full Text] [Related]
11. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
Gale MJ; Korth MJ; Katze MG
Clin Diagn Virol; 1998 Jul; 10(2-3):157-62. PubMed ID: 9741641
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
[TBL] [Abstract][Full Text] [Related]
13. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.
Gale MJ; Korth MJ; Tang NM; Tan SL; Hopkins DA; Dever TE; Polyak SJ; Gretch DR; Katze MG
Virology; 1997 Apr; 230(2):217-27. PubMed ID: 9143277
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.
François C; Duverlie G; Rebouillat D; Khorsi H; Castelain S; Blum HE; Gatignol A; Wychowski C; Moradpour D; Meurs EF
J Virol; 2000 Jun; 74(12):5587-96. PubMed ID: 10823866
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.
Saito T; Ito T; Ishiko H; Yonaha M; Morikawa K; Miyokawa A; Mitamura K
Am J Gastroenterol; 2003 Jun; 98(6):1377-83. PubMed ID: 12818284
[TBL] [Abstract][Full Text] [Related]
16. NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy.
Bouzgarrou N; Hassen E; Mahfoudh W; Gabbouj S; Schvoerer E; Ben Yahia A; Ben Mami N; Triki H; Chouchane L
J Med Virol; 2009 Dec; 81(12):2021-8. PubMed ID: 19856481
[TBL] [Abstract][Full Text] [Related]
17. Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy.
Chayama K; Suzuki F; Tsubota A; Kobayashi M; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Takahashi N; Kinoshita M; Kumada H
Hepatology; 2000 Nov; 32(5):1138-44. PubMed ID: 11050067
[TBL] [Abstract][Full Text] [Related]
18. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
19. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
[TBL] [Abstract][Full Text] [Related]
20. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
Gale M; Blakely CM; Kwieciszewski B; Tan SL; Dossett M; Tang NM; Korth MJ; Polyak SJ; Gretch DR; Katze MG
Mol Cell Biol; 1998 Sep; 18(9):5208-18. PubMed ID: 9710605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
